REV 25 mg (Revlimid 25 mg)
Generic Name: lenalidomide
Pill with imprint REV 25 mg is White, Capsule-shape and has been identified as Revlimid 25 mg. It is supplied by Celgene Corporation.
Revlimid is used in the treatment of multiple myeloma; myelodysplastic diseases; lymphoma; mantle cell lymphoma; anemia and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for REV 25 mg
Revlimid
- Generic Name:
- lenalidomide
- Imprint:
- REV 25 mg
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
Other immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Celgene Corporation
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
Note: Inactive ingredients may vary.
More about Revlimid (lenalidomide)
- Revlimid Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 10 Reviews
- Drug class: miscellaneous antineoplastics
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
